S. 3822 (109th): Genomics and Personalized Medicine Act of 2006

Introduced:
Aug 03, 2006 (109th Congress, 2005–2006)
Sponsor:
Sen. Barack Obama [D-IL]
Status:
Died (Referred to Committee)
See Instead:
This bill was re-introduced as S. 976 (110th) on Mar 23, 2007.

The bill’s title was written by the bill’s sponsor. S. stands for Senate bill.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


8/3/2006--Introduced.
Genomics and Personalized Medicine Act of 2006 - Requires the Secretary of Health and Human Services to:
(1) establish the Genomics and Personalized Medicine Interagency Working Group to expand and accelerate genetics and genomics research and translate such research into clinical and public health applications;
(2) expand and accelerate research and programs to collect genetic and genomic data that will advance the field of genomics and personalized medicine;
(3) develop a plan for a national biobanking research initiative;
(4) expand efforts to increase knowledge about the interaction between genetics and the environment and about ways in which molecular genetic screening, diagnostics, and treatments may be used to improve the health and health care of racial and ethnic minority populations;
(5) increase recruitment and retention of trainees in genetics and genomics;
(6) ensure the adequacy of genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders;
(7) improve the safety, efficacy, and availability of information about genetic tests; and
(8) improve the oversight and regulation of genetic tests.
Provides for the recruitment of health professionals from diverse backgrounds in the genomics workforce and improvement in the quality of genomics training.
Amends the Internal Revenue Code to establish a tax credit for qualified research expenses for the development of a qualified companion diagnostic test designed to provide information to increase the safety or effectiveness of a drug.
Provides for the expansion of adverse event reporting systems to encompass reports of adverse events resulting from genetic testing.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)